SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Research and development expenditures | Major vendors, combined | ||||||
Concentration | ||||||
Concentration Risk (as a percent) | 44.00% | 59.00% | 44.00% | 66.00% | ||
Research and development expenditures | Vendor One | ||||||
Concentration | ||||||
Concentration Risk (as a percent) | 63.00% | 55.00% | ||||
Accounts payable and accrued expense | Major vendors, combined | ||||||
Concentration | ||||||
Concentration Risk (as a percent) | 65.00% | 54.00% | ||||
Accounts payable and accrued expense | Vendor One | ||||||
Concentration | ||||||
Concentration Risk (as a percent) | 53.00% | 56.00% |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|